Anti-Thymocyte Globulin (ATG)-Free Nonmyeloablative Haploidentical PBSCT Plus Post-Transplantation Cyclophosphamide Is a Safe and Efficient Treatment Approach for Pediatric Acquired Aplastic Anemia

Anti-Thymocyte Globulin (ATG)-Free Nonmyeloablative Haploidentical PBSCT Plus Post-Transplantation Cyclophosphamide Is a Safe and Efficient Treatment Approach for Pediatric Acquired Aplastic Anemia

Most cases of acquired aplastic anemia (AA) arise from autoimmune destruction of hematopoietic stem and progenitor cells. Human leukocyte antigen (HLA)-haploidentical nonmyeloablative hematopoietic stem cell transplantation (HSCT) plus post-transplantation cyclophosphamide (PTCy) is increasingly app...

Full description

Bibliographic Details
Main Authors:	Rong-Long Chen, Peng Peng Ip, Jy-juinn Shaw, Yun-Hsin Wang, Li-Hua Fan, Yi-Ling Shen, Nithila A. Joseph, Tsen-Erh Chen, Liuh-Yow Chen
Format:	Article
Language:	English
Published:	MDPI AG 2022-12-01
Series:	International Journal of Molecular Sciences
Subjects:	anti-thymocyte globulin nonmyeloablative haploidentical peripheral blood stem cell transplantation post-transplantation cyclophosphamide <i>SAMD9L</i> variant severe aplastic anemia
Online Access:	https://www.mdpi.com/1422-0067/23/23/15192

Similar Items

Evolution of Graves’ Disease during Immune Reconstitution following Nonmyeloablative Haploidentical Peripheral Blood Stem Cell Transplantation in a Boy Carrying Germline <i>SAMD9L</i> and <i>FLT3</i> Variants
by: Peng Peng Ip, et al.
Published: (2022-08-01)

Upfront haploidentical transplant for acquired severe aplastic anemia: registry-based comparison with matched related transplant
by: Lan-Ping Xu, et al.
Published: (2017-01-01)

Who is the best haploidentical donor for acquired severe aplastic anemia? Experience from a multicenter study
by: Lan-Ping Xu, et al.
Published: (2019-09-01)

Haploidentical Hematopoietic Stem Cell Transplantation for Patients with Severe Aplastic Anemia—Single-Centre Experience
by: Vered Stavi, et al.
Published: (2024-02-01)

Low-dose post-transplant cyclophosphamide and anti-thymocyte globulin as an effective strategy for GVHD prevention in haploidentical patients
by: Yu Wang, et al.
Published: (2019-09-01)

Haploidentical Stem Cell Transplantation With a Novel Conditioning Regimen in Older Patients: A Prospective Single-Arm Phase 2 Study
by: Yu-Qian Sun, et al.
Published: (2021-02-01)

Combination of Haploidentical Hematopoietic Stem Cell Transplantation with Umbilical Cord-Derived Mesenchymal Stem Cells in Patients with Severe Aplastic Anemia: A Retrospective Controlled Study
by: Xian-fu Sheng, et al.
Published: (2022-05-01)

Comparison of Haploidentical Hematopoietic Stem Cell Transplant With or Without Unrelated Cord Blood Infusion in Severe Aplastic Anemia: Outcomes of a Multicenter Study
by: Meiqing Lei, et al.
Published: (2022-06-01)

Safety and Efficacy of Haploidentical Peripheral Blood Stem Cell Transplantation for Myeloid Malignancies Using Post-transplantation Cyclophosphamide and Anti-thymocyte Globulin as Graft-versus-Host Disease Prophylaxis
by: Maria Queralt Salas, et al.
Published: (2019-06-01)

Aplastic anemia complicating eosinophilic fasciitis: a literature review
by: T. Larocca Skare, et al.
Published: (2023-12-01)

Haploidentical Stem Cell Transplantation in Lymphomas—Expectations and Pitfalls
by: Jacopo Mariotti, et al.
Published: (2020-11-01)

Comparisons Between Frontline Therapy and a Combination of Eltrombopag Plus Immunosuppression Therapy and Human Leukocyte Antigen-Haploidentical Hematopoietic Stem Cell Transplantation in Patients With Severe Aplastic Anemia: A Systematic Review
by: Yuan Yang, et al.
Published: (2021-04-01)

Low-dose anti-thymocyte globulin plus low-dose post-transplant cyclophosphamide-based regimen for prevention of graft-versus-host disease after haploidentical peripheral blood stem cell transplants: a large sample, long-term follow-up retrospective study
by: Xingying Li, et al.
Published: (2023-10-01)

Comparison of intensive immunosuppressive therapy with haploidentical transplantation for young severe aplastic anemia
by: CHEN Miao, WU Ya-mei, ZHOU Dao-bin, DUAN Ming-hui, ZHUANG Jun-ling, HAN Bing, WU Xiao-xiong
Published: (2020-06-01)

Clinical evaluation of haploidentical hematopoietic combined with human umbilical cord-derived mesenchymal stem cells in severe aplastic anemia
by: Lixin Xu, et al.
Published: (2018-03-01)

Modest dose anti-thymocyte globulin administered intraoperatively is safe and effective in kidney transplantations: a retrospective study
by: Hui-Ying Liu, et al.
Published: (2019-08-01)

Low-dose post-transplant cyclophosphamide with G-CSF/ATG based haploidentical protocol provides favorable outcomes for SAA patients
by: Xiaodi Ma, et al.
Published: (2023-05-01)

Influence of ABO compatibility on haploidentical hematopoietic stem-cell transplant
by: Rajesh B Sawant, et al.
Published: (2023-01-01)

Modified combination of anti-thymocyte globulin (ATG) and post-transplant cyclophosphamide (PTCy) as compared with standard ATG protocol in haploidentical peripheral blood stem cell transplantation for acute leukemia
by: Maryam Barkhordar, et al.
Published: (2022-08-01)

The Incidence, Outcomes, and Risk Factors of Secondary Poor Graft Function in Haploidentical Hematopoietic Stem Cell Transplantation for Acquired Aplastic Anemia
by: Fan Lin, et al.
Published: (2022-05-01)

Post-transplant cyclophosphamide or cell selection in haploidentical allogeneic hematopoietic cell transplantation?
by: Razan Mohty, et al.
Published: (2024-12-01)

Outcomes of Bone Marrow Compared to Peripheral Blood for Haploidentical Transplantation
by: Nidhi Sharma, et al.
Published: (2021-06-01)

Strategies in Haploidentical Stem Cell Transplantation in Adults
by: Ulaş D. Bayraktar, et al.
Published: (2013-12-01)

Delayed kidney transplantation after HLA-haploidentical hematopoietic cell transplantation in a young woman with myelodysplastic syndrome with renal failure
by: Kevin C. Miller, et al.
Published: (2022-01-01)

Real-world experience of treatment with thrombopoietin receptor agonists in anti-thymocyte globulin-naïve patients with aplastic anemia: an observational retrospective analysis in a single institution
by: Masaki Iino, et al.
Published: (2022-12-01)

Allogeneic stem cell transplant in a patient with aplastic anemia with bacteremia and candidemia
by: Sharat Damodar
Published: (2008-12-01)

Sirolimus as long-term graft-versus-host-disease prophylaxis in haploidentical hematopoietic stem cell transplant recipients for non-malignant disorders is associated with high incidence of acneiform lesions
by: Aditi Chakrbarti, et al.
Published: (2015-01-01)

Microvascular Complications in Type 1 Diabetes: A Comparative Analysis of Patients Treated with Autologous Nonmyeloablative Hematopoietic Stem-Cell Transplantation and Conventional Medical Therapy
by: Jaquellyne G. Penaforte-Saboia, et al.
Published: (2017-11-01)

Retrospective Comparison of Efficacy and Safety of Rabbit Anti-Thymocyte Globulin and Porcine Anti-Lymphocyte Globulin in Patients With Acquired Aplastic Anemia Undergoing Hematopoietic Stem Cell Transplantation From Matched Sibling Donors
by: Yuanfeng Zhang, et al.
Published: (2022-06-01)

Outcome of children with severe acquired aplastic anemia treated with rabbit antithymocyte globulin and cyclosporine A
by: Marlene Pereira Garanito, et al.
Published: (2014-09-01)

Increased risk of 100-day and 1-year infection-related mortality and complications in haploidentical stem cell transplantation
by: Chang J, et al.
Published: (2019-05-01)

New‐onset posttransplant diabetes mellitus after haploidentical hematopoietic cell transplantation with posttransplant cyclophosphamide
by: Brendan L. Mangan, et al.
Published: (2020-11-01)

The Anti-thymocyte Globulin use makes kidney transplantation journey smooth
by: Akbar Mahmood Sultan, et al.
Published: (2018-06-01)

Real‐world experience: Introduction of T cell replete haploidentical transplantations in a single center
by: Gwendolyn vanGorkom, et al.
Published: (2021-08-01)

T‐cell replete haploidentical stem cell transplantation with low dose anti‐thymocyte globulin for relapsed/refractory Ewing sarcoma family tumors
by: Hideki Sano, et al.
Published: (2022-07-01)

Current status of conditioning regimens in haploidentical hematopoietic cell transplantation
by: Junichi Sugita, et al.
Published: (2024-12-01)

Impact of Induction Immunosuppressants on T Lymphocyte Subsets after Kidney Transplantation: A Prospective Observational Study with Focus on Anti-Thymocyte Globulin and Basiliximab Induction Therapies
by: Hyung Duk Kim, et al.
Published: (2023-09-01)

CMV Infection and CMV-Specific Immune Reconstitution Following Haploidentical Stem Cell Transplantation: An Update
by: Xiao-Hua Luo, et al.
Published: (2021-10-01)

Comparison of Alemtuzumab and Anti-thymocyte Globulin Treatment for Acute Kidney Allograft Rejection
by: Marieke van der Zwan, et al.
Published: (2020-07-01)

Outcome Comparison between Low-Dose Rabbit Anti-Thymocyte Globulin and Basiliximab in Low-Risk Living Donor Kidney Transplantation
by: Sang Jin Kim, et al.
Published: (2020-05-01)